Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,424
Closed -$155K 2007
2025
Q4
$155K Buy
+45,424
New +$220K 0.01% 1099
2025
Q2
Sell
-26,240
Closed -$143K 1781
2025
Q1
$143K Buy
+26,240
New +$149K 0.01% 879
2024
Q3
Sell
-11,206
Closed -$77K 1648
2024
Q2
$77K Sell
11,206
-13,049
-54% -$119K 0.01% 855
2024
Q1
$249K Buy
+24,255
New +$179K 0.02% 692
2023
Q3
Sell
-26,510
Closed -$115K 1617
2023
Q2
$115K Buy
+26,510
New +$58.9K 0.01% 996
2023
Q1
Sell
-32,098
Closed -$62K 1815
2022
Q4
$62K Buy
+32,098
New +$72K 0.01% 1043
2022
Q1
Sell
-12,046
Closed -$47K 1778
2021
Q4
$47K Buy
+12,046
New +$56.9K ﹤0.01% 1357
2021
Q2
Sell
-11,168
Closed -$177K 1805
2021
Q1
$177K Buy
+11,168
New +$201K 0.01% 1130

Other funds holding LFMD

Virtu Financial's LFMD Position: Q1 2026 in Review

Virtu Financial sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 45,424 shares — an estimated $155K sold.

Virtu Financial first reported a position in LFMD in Q1 2021 and held it in 8 quarters. The position peaked at $249K in Q1 2024. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Virtu Financial reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 45,424 LifeMD shares in Q1 2026, an estimated $155K.
  • Virtu Financial first reported a position in LifeMD in Q1 2021 and held it in 8 quarters.
  • Virtu Financial's LifeMD position peaked at $249K in Q1 2024.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.